Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pediatric demyelinating diseases.
Microglia and neuroprotection.
Month of birth and risk of multiple sclerosis: confounding and adjustments.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
First case report of acute hemorrhagic leukoencephalitis following Plasmodium vivax infection.
Targeting the B7 Family of Co-Stimulatory Molecules : Successes and Challenges.
Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?.
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
Serum sickness reaction with skin involvement induced by bee venom injection therapy.
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.
MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.

Pages